The facility produces a wide range of APIs, with a special focus on oncology and other niche speciality segments
Mac-Chem Products (India) announced the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP certification for its manufacturing facility in Boisar. The approval marks a significant milestone for Mac-Chem in its journey of global leadership. The audit was conducted in October 2023 by Swissmedic Swiss Agency for Therapeutic Products.
Speaking on the development, Manish Jain, Director, Mac-Chem said, “We are delighted with the successful renewal of our EU-GMP certification. The achievement affirms our commitment to the highest standards of quality and compliance aligning with European regulations. The timely approval further reaffirms our commitment to delivering high-quality pharma products that positively impact patient care globally.”
The EU-GMP certification underlines the Boisar facility’s capabilities to ensure consistent and controlled production by EU quality standards. The facility produces a wide range of APIs, with a special focus on oncology and other niche speciality segments.
